داروسازی کوثر
دکوثر | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 19,910 2.97
Close Price: 19,980
Financial Ratios
AGM
Interim
2026/04/26 Fiscal Year 2025/12/2112 Month | 2025/08/06 Fiscal Year 2025/03/2012 Month | ||
|---|---|---|---|
Net Profit to Sales | 13.32 | 2.42 | |
Gross Profit to Sales | 13.32 | 2.88 | |
Operating Margin | -23.06 | 14.19 | |
Gross Profit to Sales | -12.1 | 23.13 | |
Net Profit to Gross Profit | -110.05 | 10.47 | |
Return on Assets (ROA) | 4.38 | 2.07 | |
Return on Capital (%) | 30.7 | 22.53 | |
Return on Equity (ROE) | 9.18 | 8.21 | |
Working Capital Return | 19.97 | 7.84 | |
Fixed Asset Return | 13.31 | 35.51 | |
Loan Benefit Assessment | 2.1 | 3.96 | |
Current Ratio | 1.51 | 1.4 | |
Quick Ratio | 1.07 | 1.01 | |
Liquidity Ratio | 0.12 | 0.05 | |
Net Working Capital | 5,226,383 | 4,887,276 | |
Current Assets Ratio | 0.65 | 0.92 | |
Inventory Turnover | 192.64 | 143.3 | |
Receivables Collection Period | 426.33 | 258.43 | |
Inventory to Working Capital | 0.86 | 0.98 | |
Working Capital Turnover | 1.5 | 3.24 | |
Fixed Asset Turnover | 1 | 14.66 | |
Total Asset Turnover | 0.33 | 0.86 | |
Debt Ratio | 0.52 | 0.75 | |
Debt to Equity | 1.1 | 2.96 | |
Long-Term Debt to Equity | 0.16 | 0.37 | |
Current Debt to Equity | 0.91 | 2.59 | |
Equity Ratio | 47.72 | 25.26 | |
Debt Coverage Ratio | 4.36 | 0.63 |